Aptima Vaginal Swab Testing
When performing an Aptima vaginal swab, you should order the Aptima BV (Bacterial Vaginosis) assay and/or the Aptima CV/TV (Candida/Trichomonas Vaginitis) assay, depending on the clinical presentation—these are nucleic acid amplification tests (NAATs) that detect the three most common causes of infectious vaginitis. 1
Understanding the Aptima Platform
The Aptima system uses transcription-mediated amplification (TMA) technology to diagnose vaginitis. There are two separate assays available:
1. Aptima BV Assay
- Detects bacterial vaginosis by measuring the loads of:
- Gardnerella vaginalis
- Atopobium vaginae
- Lactobacillus species (in relation to overall bacterial load)
- Demonstrates 95.0% sensitivity and 89.6% specificity compared to Nugent scoring 2
- Shows 98.8% sensitivity and 77.7% specificity against Hay/Ison criteria 3
2. Aptima CV/TV Assay
- Combined test detecting:
- Candida species (C. albicans and resistant species like C. glabrata/krusei)
- Trichomonas vaginalis
- For Candida: 91.7% sensitivity and 94.9% specificity 2
- For T. vaginalis: 96.5% sensitivity and 95.1% specificity 2
Clinical Decision Algorithm
Order based on symptoms:
- Abnormal vaginal discharge with pH >4.5 and/or fishy odor → Order Aptima BV
- Abnormal vaginal discharge with pH <4.5 and/or vulvar symptoms → Order Aptima CV/TV
- Undifferentiated vaginal symptoms or mixed presentation → Order both assays
The Aptima assays significantly outperform traditional methods (wet mount sensitivity 40-80%, culture for Trichomonas ~70%) 1, 4.
Specimen Collection
The vaginal swab should be:
- Collected from vaginal discharge or vaginal epithelium
- Placed in laboratory-provided transport medium specific to the Aptima system
- Stored at room temperature for up to 7 days (or per manufacturer's recommendations) 1
Important note: The same specimen collection device is often used for Chlamydia trachomatis/Neisseria gonorrhoeae NAAT testing, allowing simultaneous STI screening 1.
Key Advantages Over Traditional Methods
The Aptima assays demonstrate higher sensitivity and specificity than clinicians' diagnoses and in-clinic assessments (wet mount, pH testing, whiff test) 2. This is particularly important because:
- Wet mount microscopy requires live organisms and has poor sensitivity (40-70%) 1
- Traditional culture methods miss many infections
- Point-of-care tests have widely variable performance 1
Common Pitfalls to Avoid
- Don't rely solely on clinical criteria (Amsel criteria, pH testing)—molecular testing is superior 1
- Be aware of increased detection rates: Aptima assays may identify asymptomatic colonization, potentially leading to higher treatment rates 5
- For intermediate Nugent scores: Aptima BV testing is particularly useful for clarifying diagnosis 6
- In recurrent cases: Consider adding antifungal susceptibility testing if Candida is detected 1, 7
The Aptima platform represents the current standard for molecular diagnosis of vaginitis, with FDA clearance for symptomatic females and validated performance across multiple clinical studies 1, 3, 2.